Physicians Interactive acquires Univadis
Merck owns both Physicians Interactive and Univadis. Financial terms of transaction were not disclosed. Univadis’s membership includes over 3 million healthcare providers in more than 90 countries. It
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Onivyde, in combination with chemotherapy drugs fluorouracil (5-FU) and leucovorin has been approved for treatment of metastatic pancreatic cancer patients who have undergone gemcitabine-based chemotherapy. The drug’s effectiveness
With complementary strengths in real-world data management, operational delivery, advanced analytics, and scientific and therapeutic expertise, the collaboration will accelerate assessments of treatment impact and help improve patient
Delivered to physicians through DrFirst’s myBenefitCheckSM, the IntelligentRx service provides doctors with patient-specific prescription price information at the time the prescription is being written. The service is expected